Amgen (Nasdaq: AMGN) recently announced it will invest $650 million to expand its biologics manufacturing facility in Juncos, Puerto Rico, a move expected to create nearly 750 jobs across construction and advanced manufacturing. The expansion will increase drug production capacity and integrate advanced technologies into operations, part of the company’s strategy to bolster its U.S.… The post Amgen to invest $650M in Puerto Rico biologics facility appeared first on Pharmaceutical Processi...| Pharmaceutical Processing World
Amgen announced May 2nd financial results for the first quarter 2024, and its shares soared right after the announcement, which was followed closely by a FDA approval of a lung-cancer drug. “With many of our innovative products delivering strong growth and promising new medicines advancing through our pipeline, we are excited about delivering attractive long-term […] The post Amgen Shares Value Rose After Financial Results And New Drug Related Announcement appeared first on Healthcare Wee...| Healthcare Weekly